LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-3.4%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.61B
AUM Growth
+$1.61B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-14.54%
Top 10 Holdings %
Top 10 Hldgs %
19.7%
Holding
510
New
10
Increased
104
Reduced
55
Closed
293
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$13.2M |
| 2 |
Pinduoduo
PDD
|
$12.2M |
| 3 |
Futu Holdings
FUTU
|
$12.1M |
| 4 |
Huazhu Hotels Group
HTHT
|
$8.49M |
| 5 |
Fate Therapeutics
FATE
|
$7.52M |
Top Sells
| 1 |
InMode
INMD
|
$23.9M |
| 2 |
QuidelOrtho
QDEL
|
$14.1M |
| 3 |
Halozyme
HALO
|
$13.6M |
| 4 |
Trip.com Group
TCOM
|
$13M |
| 5 |
Amazon
AMZN
|
$12.8M |
Sector Composition
| 1 | Healthcare | 53.98% |
| 2 | Consumer Discretionary | 13.16% |
| 3 | Financials | 11.73% |
| 4 | Technology | 5.09% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Allogene Therapeutics
ALLO
$249M
| $23.5M | 1.46% |
914,416
+140,854
| +18% | +$3.62M |
|
27
Equity Lifestyle Properties
ELS
$11.7B
| $23.4M | 1.46% |
300,000
-80,000
| -21% | -$6.25M |
|
28
Chemed
CHE
$6.7B
| $23.3M | 1.44% |
50,000
| – | – |
|
29
AbbVie
ABBV
$374B
| $23.2M | 1.44% |
216,139
-25,000
| -10% | -$2.68M |
|
30
Twist Bioscience
TWST
$1.57B
| $23.2M | 1.44% |
216,884
+20,208
| +10% | +$2.16M |
|
31
Medifast
MED
$153M
| $23.1M | 1.44% |
120,000
+35,000
| +41% | +$6.74M |
|
32
Neurocrine Biosciences
NBIX
$13.5B
| $23M | 1.43% |
239,983
+23,192
| +11% | +$2.22M |
|
33
Pultegroup
PHM
$26.3B
| $21.8M | 1.36% |
475,734
-765
| -0.2% | -$35.1K |
|
34
Iovance Biotherapeutics
IOVA
$800M
| $21.4M | 1.33% |
869,540
+80,978
| +10% | +$2M |
|
35
10x Genomics
TXG
$1.66B
| $20.8M | 1.29% |
142,772
+39,858
| +39% | +$5.8M |
|
|
NVTA
36
DELISTED
Invitae Corporation
NVTA
| $20.6M | 1.28% |
723,542
+67,405
| +10% | +$1.92M |
|
|
LHCG
37
DELISTED
LHC Group LLC
LHCG
| $20.4M | 1.27% |
130,000
-5,000
| -4% | -$785K |
|
38
Intellia Therapeutics
NTLA
$1.26B
| $20M | 1.24% |
148,806
-6,395
| -4% | -$858K |
|
39
Apple
AAPL
$3.54T
| $19.8M | 1.23% |
150,591
+14,628
| +11% | +$1.92M |
|
|
IMGN
40
DELISTED
Immunogen Inc
IMGN
| $17.1M | 1.06% |
3,013,467
+358,629
| +14% | +$2.03M |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.5M | 1.02% |
93,157
+19,447
| +26% | +$3.44M |
|
42
Microsoft
MSFT
$3.76T
| $16.3M | 1.01% |
62,178
+6,372
| +11% | +$1.67M |
|
43
BioNTech
BNTX
$24.1B
| $16.1M | 1% |
59,023
-34,816
| -37% | -$9.5M |
|
|
44
InMode
INMD
$917M
| $15.9M | 0.99% |
100,000
-150,000
| -60% | -$23.9M |
|
45
iShares MSCI India ETF
INDA
$9.29B
| $15.5M | 0.96% |
340,600
-10,600
| -3% | -$482K |
|
|
MDRX
46
DELISTED
Veradigm Inc. Common Stock
MDRX
| $15.2M | 0.95% |
1,140,475
+143,120
| +14% | +$1.91M |
|
|
NBIS
47
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $14.2M | 0.88% |
184,760
| – | – |
|
|
DRNA
48
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $14.1M | 0.88% |
701,305
+65,294
| +10% | +$1.32M |
|
49
American Well
AMWL
$112M
| $14M | 0.87% |
1,533,028
+361,966
| +31% | +$3.3M |
|
|
50
Pinduoduo
PDD
$177B
| $13.5M | 0.84% |
150,940
+136,583
| +951% | +$12.2M |
|